Korsana Biosciences
PrivateLast Round
PIPE
Apr 1, 2026
Total Funding Raised
$425M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Korsana Biosciences is a biotechnology company developing brain-penetrant therapeutics for neurodegenerative diseases using its proprietary blood-brain barrier shuttle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Korsana Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Korsana Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Apr 1, 2026 | ||||
| Seed | Feb 18, 2026 | ||||
| Series A | Sep 1, 2025 | ||||
| Seed | Dec 1, 2024 |
Key People
Founding team and executive leadership
Korsana Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | PIPE, Seed, Series A |
| RA Capital Management | PIPE |
| TCG Crossover | PIPE, Seed, Series A |
| Forbion | PIPE |
| Fairmount Funds Management | Seed, PIPE |
| Commodore Capital | PIPE |
| Kalehua Capital Management | PIPE |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 53% QoQ from 17 to 26 employees.
- Apr 1, 2026
$380M round led by Venrock and Fairmount Funds Management.
Korsana Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Korsana Biosciences's valuation, stock price, and market status.